These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29878687)

  • 1. Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on?
    Bhoday J; Glimelius B; Tait D; Glynne-Jones R; Adams R; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():97-99. PubMed ID: 29878687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Session 3: Many ways to organ preserve the rectum but which is correct?
    Read J; Tekkis P; Rullier E; Nicholls J; Mortensen N; Marks J; Steele RJC; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():82-87. PubMed ID: 29878680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Session 3: Beyond TME and radiotherapy MRI evaluation of rectal cancer treatment response.
    Patel UB; Blomqvist L; Chau I; Nicholls J; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():76-81. PubMed ID: 29878685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Session 4: Trying to augment response with chemotherapy: a triumph of hope over experience?
    Battersby NJ; Perez RO; Baxter N; Moran B; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():100-102. PubMed ID: 29878682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
    Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
    JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers for recurrence and sensitivity to preoperative chemoradiotherapy in locally advanced rectal tumours.
    Romain B; Meyer N; Brigand C; Chenard MP; Schneider A; Guenot D
    Dig Surg; 2014; 31(4-5):347-53. PubMed ID: 25503074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Session 3: Boosting primary and recurrent rectal cancer: how far can we push the radiotherapy envelope?
    Balyasnikova S; Vuong T; Wale A; Chong I; Rutten H; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():88-91. PubMed ID: 29878674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
    Ryan JE; Warrier SK; Lynch AC; Heriot AG
    Colorectal Dis; 2015 Oct; 17(10):849-61. PubMed ID: 26260213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
    Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Session 2: Are we ready for primary chemotherapy in rectal cancer: who, when, why?
    Patel UB; Cervantes A; Fernández-Martos C; Sclafani F; Cunningham D; Nilsson P; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():56-60. PubMed ID: 29878678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Session 4: Shaping radiotherapy for rectal cancer: should this be personalized?
    Dattani M; Marijnen C; Moran B; Tait D; Cunningham C; Rodriguez-Bigas M; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():92-96. PubMed ID: 29878670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
    Yu SK; Tait D; Chau I; Brown G
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients.
    Tokuhara K; Ueyama Y; Nakatani K; Yoshioka K; Kon M
    World J Surg Oncol; 2016 Apr; 14():136. PubMed ID: 27129578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial.
    Lefèvre JH; Mineur L; Cachanado M; Denost Q; Rouanet P; de Chaisemartin C; Meunier B; Mehrdad J; Cotte E; Desrame J; Karoui M; Benoist S; Kirzin S; Berger A; Panis Y; Piessen G; Saudemont A; Prudhomme M; Peschaud F; Dubois A; Loriau J; Tuech JJ; Meurette G; Lupinacci R; Goasguen N; Creavin B; Simon T; Parc Y;
    Ann Surg; 2019 Nov; 270(5):747-754. PubMed ID: 31634178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining and predicting early recurrence in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Zheng Z; Wang X; Huang Y; Lu X; Huang Z; Chi P
    Eur J Surg Oncol; 2020 Nov; 46(11):2057-2063. PubMed ID: 32782202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-based EMVI positivity predicts systemic recurrence in rectal cancer patients with a good tumor response to chemoradiotherapy followed by surgery.
    Cho MS; Park YY; Yoon J; Yang SY; Baik SH; Lee KY; Kim IY; Kim NK
    J Surg Oncol; 2018 Jun; 117(8):1823-1832. PubMed ID: 29790177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MRI for Diagnosing Extramural Venous Invasion in Rectal Cancer after Neoadjuvant Therapy: A Prognostic Biomarker.
    Méndez RJ; Ayuso JR
    Radiology; 2023 Aug; 308(2):e231661. PubMed ID: 37581500
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer.
    Shiraishi T; Sasaki T; Ikeda K; Tsukada Y; Nishizawa Y; Ito M
    BMC Cancer; 2019 Dec; 19(1):1222. PubMed ID: 31842797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases.
    Cho H; Kim JE; Kim KP; Yu CS; Kim JC; Kim JH; Lee MA; Jang HS; Oh ST; Kim SY; Oh JH; Kim DY; Hong YS; Kim TW
    Am J Clin Oncol; 2016 Dec; 39(6):623-629. PubMed ID: 27322695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.